PUBLISHED: 2002
              CATEGORY: Health care providers
              TYPE: External Link Exposure to thimerosal in vaccines used in Canadian infant immunization programs, with respect to risk of neurodevelopmental disorders
      
  
          Exposure to thimerosal in vaccines used in Canadian infant immunization programs, with respect to risk of neurodevelopmental disorders Exposure to thimerosal in vaccines used in Canadian infant immunization programs, with respect to risk of neurodevelopmental disorders
Examines the risk of neurodevelopmental disorders, including autism, in Canadian children as a result of mercury exposure from thimerosal-containing vaccines routinely used in some provincial/territorial universal infant and early childhood immunization programs
    Authors: Bigham M et al.
    
            
    Journal Issue: 9
    
        
    Journal Title: Canada Communicable Disease Report
    
        
    Journal Volume: 28
    
        
    Pages: 69-80
    
        
    Publisher: Publisher
              Public Health Agency of Canada
    
  
        
    
  
   
              
